Pfizer Genomic Care Grant for Metastatic Breast Cancer 2026

The Pfizer Genomic Care Grant for Metastatic Breast Cancer 2026 supports healthcare education initiatives aimed at improving genomic literacy and communication in the management of metastatic breast cancer. This program seeks to bridge gaps in understanding, interpreting, and communicating genomic testing in clinical practice, ultimately enhancing clinical decision-making and patient engagement in oncology care.

🌟 About the Grant

The program is designed to:

• Improve genomic literacy among healthcare professionals.
• Enhance communication regarding genomic testing in metastatic breast cancer management.
• Support clinical decision-making and patient engagement in oncology care.

💰 Benefits

• Funding Amount:
  • Multicountry individual projects requesting up to $100,000.00 will be considered.
  • Smaller funding requests (around $35,000.00) are also encouraged.
• Award Coverage:
  • Direct costs.
  • Institutional overhead costs (capped at 28% per Pfizer policy).
  • Indirect costs.
• Number of Awards: Funding will be awarded to support up to ten selected studies, whether national or multi-country.

✅ Eligibility Criteria

The following organizations are eligible to apply:

• Medical, nursing, allied health, and/or pharmacy professional schools.
• Healthcare institutions (both large and small).
• Professional organizations/medical societies.
• Medical education companies.
• Other entities with a mission related to healthcare professional education and/or healthcare improvement.

Additional Requirements:

• Only organizations are eligible to receive grants, not individuals or medical practice groups.
• If the project involves multiple departments or institutions, all must have a relevant role, and the requesting organization must play a key role.
• The applicant must be the project/program lead or an authorized designee (e.g., grant coordinator).
• The project/program lead must be an employee or contractor of the requesting organization.
• The requesting organization must be legally able to receive award funding directly from Pfizer LLC. Applicants are strongly encouraged to confirm this with their organization before applying.
• For projects offering continuing education credit, the requesting organization must be accredited.
• For Indian institutions: A valid and active FCRA (for the entire duration of the grant) is mandatory to receive foreign funding.
• For Italy only: Educazione Continua in Medicina (ECM) events will not be supported. Only non-ECM initiatives will be evaluated.

📅 Application Deadline

• Deadline: 22 July, 2026

📝 Application Process

• Visit the application website to apply for the Pfizer Genomic Care Grant for Metastatic Breast Cancer.

📄 Additional Information

For more details, you can view the official Pfizer Genomic Care Grant document.

🌐 Contact Information

For any inquiries or further clarification, please contact Pfizer directly through their official channels.

• Multicounty individual projects can request up to $100,000.00, with smaller requests encouraged.
• Award amounts include direct costs, institutional overhead costs (capped at 28% per Pfizer policy), and indirect costs.